ASXL1 and acute myeloid leukemia: Whether through mutated histone writers/erasers (eg DOT1L co-option by MLL fusions, or ASXL1 loss affecting PRC2) or through broader chromatin architecture mutations, AML cells often enforce an abnormal epigenetic state that locks cells into an undifferentiated, proliferative phenotype.